Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 76

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 4
Chunk 76
---
iii) the unaudited Consolidated Statements of Comprehensive Loss, (iv) the unaudited Consolidated Statements of Cash
    Flows, (v) the unaudited Consolidated Statements of Change in Stockholders’ Equity (Deficit), and (vi) Notes to Consolidated
    Financial Statements.

    +
     
    Filed
    herewith.

    ++
     
    Management
    contract or compensatory plan or arrangement.

    *
     
    Exhibit
    32.1 is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act
    of 1934, as amended, or otherwise subject to the liability of that section, nor shall such exhibit be deemed to be incorporated by
    reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Securities Exchange
    Act, except as otherwise stated in such filing.

    **
     
    XBRL
    information is filed herewith.

    104
     
    Cover
    Page Interactive Data File (embedded within the Inline XBRL document)

28

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    May
    12, 2025
    IMUNON,
    INC.

    Registrant

    By:
    /s/
    Stacy R. Lindborg Ph.D.

    Stacy
    R. Lindborg, Ph.D.

    Chief
    Executive Officer

    By:
    /s/
    David Gaiero

    David
    Gaiero

    Chief
    Financial Officer

29